Literature DB >> 1898683

Hepatic hemangioblastoma. An unusual presentation in a patient with von Hippel-Lindau disease.

A M Rojiani1, D A Owen, K Berry, B Woodhurst, F H Anderson, C H Scudamore, S Erb.   

Abstract

We report a case of multiple capillary hemangioblastomas of the liver occurring in a patient with von Hippel-Lindau disease and a history of previous cerebellar and spinal hemangioblastomas. Although rare examples of this tumor have previously been recorded in the pancreas, kidney, and urinary bladder, this appears to be the first recorded case with hepatic involvement. The histology and immunohistochemical appearance of this neoplasm are identical with those of the cerebellar tumor. We believe it represents a separate primary neoplasm rather than metastatic disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898683

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

Review 1.  Surgicopathological classification of hepatic space-occupying lesions: a single-center experience with literature review.

Authors:  Wen-Ming Cong; Hui Dong; Lu Tan; Xu-Xu Sun; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.

Authors:  Erinn B Rankin; Debra F Higgins; Jacqueline A Walisser; Randall S Johnson; Christopher A Bradfield; Volker H Haase
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

3.  Congenital extraneural hemangioblastoma in a lamb.

Authors:  Turan Yaman; Abdullah Karasu; Ahmet Uyar; Yağmur Kuşçu; Ömer Faruk Keleş
Journal:  J Vet Diagn Invest       Date:  2019-02-17       Impact factor: 1.279

Review 4.  The VHL tumor suppressor in development and disease: functional studies in mice by conditional gene targeting.

Authors:  Volker H Haase
Journal:  Semin Cell Dev Biol       Date:  2005-04-26       Impact factor: 7.727

5.  Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

Authors:  V H Haase; J N Glickman; M Socolovsky; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

Review 6.  Central nervous system capillary haemangioblastoma: the pathologist's viewpoint.

Authors:  Mahmoud R Hussein
Journal:  Int J Exp Pathol       Date:  2007-10       Impact factor: 1.925

7.  Unique association of non-functioning pheochromocytoma, ganglioneuroma, adrenal cortical adenoma, hepatic and vertebral hemangiomas in a patient with a new intronic variant in the VHL gene.

Authors:  G P Bernini; A Moretti; M Mannelli; T Ercolino; M Bardini; D Caramella; C Taurino; A Salvetti
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

Review 8.  The VHL tumor suppressor and HIF: insights from genetic studies in mice.

Authors:  P P Kapitsinou; V H Haase
Journal:  Cell Death Differ       Date:  2008-01-25       Impact factor: 15.828

Review 9.  The VHL tumor suppressor: master regulator of HIF.

Authors:  Volker H Haase
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

10.  Hemangioblastoma in the lung: metastatic or primary lesions?

Authors:  Li Lu; Peter A Drew; Anthony T Yachnis
Journal:  Case Rep Pathol       Date:  2014-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.